Imcheck Therapeutics

Imcheck Therapeutics

Imcheck Therapeutics

ImCheck Therapeutics is a privatelyheld French biotech company pioneering the next generation of immune checkpoint modulators with a highly differentiated & diversified portfolio of firstinclass therapeutic antibodies in cancers and autoimmunity.
Founded
2015
Raised
$24.1M
Follow us
Alexa global traffic share